Acute heart failure databases in specialist departments of cardiology;Databáze akutního srdečního selhání na specializovaných kardiologických klinikách

Cor et Vasa

Volumn 50, Issue 1, 2008, Pages 12-21

  Špinar, Jindřich ^a   Aschermann, Michael ^b   Al Hiti, Hikmet ^c   Bélohlávek, Jan ^b   Dušek, Ladislav ^e   Hlinomaz, Ota ^d   Kettner, Jiří ^c   Linhart, Aleš ^b   Málek, Ivan ^c   Miklík, Roman ^a   Novák, Martin ^d   Pařenica, Jiří ^a   Vitovec, Jiří ^d  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^d ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^e MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Acute coronary syndrome; Acute heart failure; Cardiogenic shock; Mortality

Indexed keywords

ACUTE CORONARY SYNDROME; ACUTE HEART FAILURE; AGING; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOGENIC SHOCK; CAUSE OF DEATH; CONTROLLED STUDY; DATA BASE; ELECTRONIC MEDICAL RECORD; HOSPITAL PATIENT; HUMAN; HYPOTENSION; INCIDENCE; INFORMATION PROCESSING; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MORTALITY; ONLINE SYSTEM; PILOT STUDY; PROGNOSIS; RISK FACTOR;

EID: 38949163959     PISSN: 00108650     EISSN: None     Source Type: Journal    
DOI: 10.33678/cor.2008.012     Document Type: Article

References (29)

1. ACCP Consensus Committee on Pulmonary Embolism. Opinions regarding the diagnosis and management of venous thromboembolic disease. Chest 1998;113:499-504.
2. Adams KF, Fonarow GC, Enerman CL, et al. Characteristics and outcomes of patients hospitalised for heart failure in the United States: rationale design, and preliminary observations from the first 100 000 cases in the acute decompensated heart failure national registry (ADHERE). Am Heart J 2005;149:209-16.
3. Adams KF Jr., Zannad F. Clinical definition and epidemiology of advanced heart failure. Am Heart J 1998;135:S204-S215.
4. Berry C, Mudroch DR. McMurray J. Economics of chronic heart failure. Eur J Heart Fail 2001;3:283-91.
5. Burger AJ, Elkayam U, Neibaur MT, et al. Comparison of the occurrence of ventricular arrhythmias in patiens with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapy. Am J Cardiol 2001;88:35-9.
6. Burghoff D, Maurer MS, Packer M. Heart failure with a normal ejection fraction: is it really a disorder of diastolic function? Circulation 2003;107:656-8.
7. Cleland JGF, Swedberg K, Follath F, et al. The Euro-Heart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: Patient characteristics and diagnosis. Eur Heart J 2003;24:442-63.
8. Cowie MR, Mosterd A, Wood DA, et al. The epidemiology of heart failure. Eur Heart J 1997;18:208-25.
9. Fox KF, Cowie MR, Wood DA, et al. Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J 2001;22:228-36.
10. Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J 2001;22:1852-923.
11. Hochman JS, Boland J, Sleeper LA, et al. for the SHOCK Registry Investigators. Current spectrum of cardiogenic shock and effect of early revascularization on mortality: results of an international registry. Circulation 1995;91:873-81.
12. Hollenberg SM, Kavinsky CJ, Parrillo JE. Cardiogenic shock. Ann Intern Med 1999;131:47-59.
13. Ivanov R, Allen J, Calvin JE. The incidence of major morbidity in critically ill patients managed with pulmonary artery catheters: a meta-analysis. Crit Care Med 2000;28:615-9.
14. Kala P, Poloczek M, Vytiska M, a spol. Remodelace levé komory srdeční po STEMI a její vztah k akutním změnám v průběhu primární PCI. Interv Akut Kardiol 2007;6:92-5.
15. Lainchbury JG, Campbell E, Frampton CM, et al. Brain natriuretic peptide and N-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol 2003;42:728-35.
16. McGhie AL, Goldstein RA. Pathogenesis and management of acute heart failure and cardiogenic shock: role of inotropic therapy. Chest 1992;102:6265-325.
17. Morrow DA, Scirica BM, Karwatowska, et al. Effects of Ranolazine on Recurent Cardiovascular Events in patients With Non-STElevation Acute Coronary Syndromes. The MERLIN-TIMI 36 Randomized Trial. JAMA 2007;297:1775-83.
18. Nieminen MS, Boehm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure. Eur Heart J 2005;26:383-416.
19. Nieminen MS, Brutsaert D, Dickstein K, et al. Euro-Heart Failure Survey (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 2006;27:2725-36.
20. Nohria ATS, Fang JC, Lewis EF, et al. Clinical assessment identifies hemodynamic profiles that predict autcomes in patients admitted with heart failure. J Am Call Cardiol 2003;41:1797-804.
21. Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001;22:1527-60.
22. Roguin A, Behar D, Ben Ami H, et al. Long-term prognosis of acute pulmonary oedema - an ominous outcome. Eur J Heart Fail 2000;2:137-44.
23. Sosin MD, Bhatia GS, Zarifis J, et al. An 8-year follow-up study of acute admissions with heart failure in a multi-ethnic population. Eur J Heart Failure 2004;6:669-72.
24. Ševčík P, Černý V, Vítovec J, et al. Intenzivní medicína. 2. vyd. Praha: Galén, 2003:422.
25. Špinar J, Hradec J. Meluzín J, a spol. Doporučení pro diagnostiku a léčbu srdečního selhání ČKS 2006. Cor Vasa 2007;49:K5-K33.
26. Widimský P, Janoušek S, Vojáček J. Doporučení pro diagnostiku a léěbu akutního infarktu myokardu (Q - typ//s elevacemi ST//s raménkovým blokem). Cor Vasa 2002;44:K123-K143.
27. Špinar J, Janský P, Kettner J, Málek I. Doporučeni pro diagnostiku a léčbu akutního srdečního selhání. Cor Vasa 2006;48:K3-K31.
28. Špinar J, Vítovec J. Normy pro BNP a NT-proBNP stanoveny. Cor Vasa 2005;47:395-8.
29. Špinarová L, Špinar J, Vašků A, a spol. Je humorální aktivace u srdečního selhání ovlivněna genetickou predispozicí. Cor Vasa 2007;49:127-33.